MSPE in $145m Sihuan Pharmaceutical sell-down
Morgan Stanley Private Equity Asia reduced its stake in China’s Sihuan Pharmaceutical, raising HK$1.12bn ($145m) on April 2, two weeks after the company’s senior management raised a similar amount via a another transaction.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts